Discover GEMTESA® (vibegron), a New Treatment Option for Your Formulary
06/11/2021
Log in or register to view.
GEMTESA® is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.
Click on the PDF above for full prescribing information.
Current Issue
October/November/December Volume 21, Issue 4, First Report Managed CareWhat's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter